Clinical Trial Update: ANTIcoagulation in Severe COVID-19 Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on anticoagulation in patients with severe COVID-19 pneumonia; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Severe COVID-19 Pneumonia | Phase 2 | Status: COMPLETED